BIOINVENT FINANS AB
556605-9571ActiveClinical-stage biotech developing novel immuno-oncology antibody therapies for cancer.
Oversikt
- 0
- Ansatte
- Ukjent
- Omsetning
- 2001
- Grunnlagt
Nøkkelbeslutningstakere
Cecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Anette Mårtensson
Employee deputy, Member of the Board
Emma Meurling
HR Director
+18 flere kontakter i Funnelfeedr
Beskrivelse
BioInvent International AB is a clinical-stage company focused on discovering and developing novel antibody therapeutics for cancer treatment. The core of their work lies in immuno-oncology, leveraging deep expertise in immunology, cancer biology, and antibody biology. They utilize their proprietary...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Ukjent
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556605957101
- Adresse
- SÖLVEG 41, 223 70, LUND, SE
Beslutningstakere
22 kontakter i FunnelfeedrCecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Anette Mårtensson
Employee deputy, Member of the Board
Emma Meurling
HR Director
Nanna Lüneborg
Member of the Board
Andres McAllister
Chief Medical Officer
Kristoffer Bissessar
Member of the Board
Björn Frendéus
CSO
Leonard Kruimer
Chairman of the Board
Martin Welschof
Chief Executive Officer
Kristoffer Rudenholm Hansson
Senior Vice President, Technical Operations
Natalie Berner
Member of the Board
Vincent Ossipow
Member of the Board
Laura Lassouw-Polman
Member of the Board
Bernd Seizinger
Member of the Board
Sylvie Ryckebusch
Chief Business Officer
Stefan Ericsson
Chief Financial Officer
Ashley Robinson
Senior Vice President Strategy & Finance
Ingunn Munch Lindvig
Senior Vice President Regulatory Affairs
Andre kontakter
Marina Mangold
Data Protection Officer
Tomas Wall
Employee Representative
Elin Birgersson
Employee Representative
Lignende bedrifter
19 lignende bedrifter i FunnelfeedrAlligator Bioscience AB
10–19 ansatteClinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
CAEDO ONCOLOGY AS
Developing novel monoclonal antibodies for targeted cancer immunotherapy treatment.
Active Biotech AB (publ)
1–4 ansatteDeveloping novel treatments for cancer and inflammatory eye diseases.
Affibody AB
50–99 ansatteDeveloping next-generation radiopharmaceuticals using proprietary Affibody technology.
Lead Biologics International AB
1–4 ansatteExpert-led life science company developing novel antibody therapeutics for cancer.
Utforsk mer
Spørsmål om BIOINVENT FINANS AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo